Singapore: Researchers from Japan's RIKEN Center for Developmental biology have developed a new sugar and water-based so...
Singapore: US-based Cytokinetics and Japan-based Astellas Pharma entered in a two-year collaboration focused on the R&am...
Singapore: Astellas Pharma and XenoPort have launched Regnite (gabapentin enacarbil) extended-release tablets. Regnite i...
Singapore:Â The Scripps Research Institute (TSRI) and Takeda Pharmaceutical plan to expand their recent research colla...
Singapore: Japanese company I'rom Holdings will acquire an 18.8 percent stake in IDT Australia. I'rom is listed on the T...
Singapore: The Japanese unit of AstraZeneca (AZ), has been acquitted, in a case that had held the firm responsible for t...
Asia needs a solution, that goes beyond traditional structure, models and pathways, to meet the essential vaccine supply...
Singapore: Japan's Daiichi Sankyo and Ranbaxy Laboratories have plans to integrate their business operations in Thailand...
Singapore:Â A new power-free microfluidic chip developed by researchers at the RIKEN Advanced Science Institute, Japan...
Singapore: Japan based Hoya Corporation has appointed Mr Augustine Yee as its executive officer, chief legal officer and...
Singapore:Â Takeda Pharmaceuticals' Deerfield campus has been listed among Chicago's top 100 workplaces by the Chicago...
Singapore: Japan-based Eisai is going to launch its new carbonated supplement drink named 'Chocola BB Sparkling + Fiber'...
Singapore: Eisai, which has its headquarters in Tokyo, has submitted a marketing authorization application to Japan's Mi...
Singapore:Â Keryx Biopharmaceuticals announced that its Japanese partner, Japan Tobacco (JT), has filed a New Drug App...
Singapore: The US FDA has accepted Astellas Pharma's US subsidiary filing of a supplemental New Drug Application (sNDA) ...
Singapore: The European Medicines Agency (EMA) has accepted the marketing authorization application for review of an aty...
New Delhi: Ranbaxy issued an advisory claiming that all their products in the Indian and global markets are safe and eff...
Singapore: Global biopharmaceutical company Amgen plans to acquire all the outstanding shares of Onyx Pharmaceuticals fo...
Singapore: The TRILOGY ACS study, a phase III trial comparing prasugrel plus aspirin to clopidogrel plus aspirin in pati...
Singapore:Â Takeda Pharmaceutical mutually terminated its worldwide agreement with Amylin Pharmaceuticals, which was o...
Singapore: The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a posi...
Singapore: Astellas Pharma, Japan's pharmaceutical giant with net sales of $10.7 billion and net income of $881 million ...
Singapore:Â Sucampo Pharmaceuticals' subsidiary SPL has received a $15 million milestone payment from Abbott's subsidi...
Singapore:Â Eisai announched that Scotland's health technology assessment (HTA) body, the Scottish Medicines Consortiu...
Singapore:Â ZOLL Medical, a manufacturer of medical devices and related software solutions and a wholly owned US subsi...
